Genmab value drops by over USD 1.5bn after royalties defeat
![Photo: Tuala Hjarnø / Genmab / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13907151.ece/ALTERNATES/schema-16_9/doc7kh1vksydyv4yksx5v2.jpg)
Since trading opened on Friday, Genmab’s market value has dropped by DKK 10.8bn (USD 1.58bn), as news broke that arbitrators had ruled in Janssen’s favor in a royalties dispute between the two firms.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Genmab loses royalties case against Janssen
For subscribers